Rutgers Receives FDA Approval for Cancer Therapy Clinical Trials
Dimensions of Dental Hygiene
JUNE 13, 2021
Actinobac Biomed, a company founded by Rutgers School of Dental Medicine researcher Scott Kachlany, PhD, has received U.S. Food and Drug Administration approval to begin a Phase I clinical trial in patients who have relapsed or refractory leukemia of lymphoma, according to the college. Learn more at newswise.com.
Let's personalize your content